419 related articles for article (PubMed ID: 32758871)
21. Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.
Cook JR; Ausiello J
Rev Endocr Metab Disord; 2022 Apr; 23(2):151-170. PubMed ID: 34195965
[TBL] [Abstract][Full Text] [Related]
22. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.
Kuriakose J; Montezano AC; Touyz RM
Clin Sci (Lond); 2021 Jan; 135(2):387-407. PubMed ID: 33511992
[TBL] [Abstract][Full Text] [Related]
23. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
Hu Y; Liu L; Lu X
Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Wang K; Gheblawi M; Nikhanj A; Munan M; MacIntyre E; O'Neil C; Poglitsch M; Colombo D; Del Nonno F; Kassiri Z; Sligl W; Oudit GY
Hypertension; 2022 Feb; 79(2):365-378. PubMed ID: 34844421
[TBL] [Abstract][Full Text] [Related]
25. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.
Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A
Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598
[TBL] [Abstract][Full Text] [Related]
26. The fight against COVID-19: Striking a balance in the renin-angiotensin system.
Dean AQ; Bozza WP; Twomey JD; Luo S; Nalli A; Zhang B
Drug Discov Today; 2021 Oct; 26(10):2214-2220. PubMed ID: 33865979
[TBL] [Abstract][Full Text] [Related]
27. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
[TBL] [Abstract][Full Text] [Related]
28. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).
Cadegiani FA; Goren A; Wambier CG
Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806
[TBL] [Abstract][Full Text] [Related]
29. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury.
Oz M; Lorke DE
Biomed Pharmacother; 2021 Apr; 136():111193. PubMed ID: 33461019
[TBL] [Abstract][Full Text] [Related]
31. The systemic renin-angiotensin system in COVID-19.
Reindl-Schwaighofer R; Hödlmoser S; Domenig O; Krenn K; Eskandary F; Krenn S; Schörgenhofer C; Rumpf B; Karolyi M; Traugott MT; Abrahamowicz A; Tinhof V; Mayfurth H; Rathkolb V; Mußnig S; Schmölz L; Ullrich R; Heinzel A; König F; Binder C; Bonderman D; Strassl R; Puchhammer-Stöckl E; Gorkiewicz G; Aberle JH; Jilma B; Wenisch C; Poglitsch M; Oberbauer R; Zoufaly A; Hecking M
Sci Rep; 2022 Nov; 12(1):20117. PubMed ID: 36418458
[TBL] [Abstract][Full Text] [Related]
32. "When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review.
Kounis NG; Gogos C; de Gregorio C; Hung MY; Kounis SN; Tsounis EP; Assimakopoulos SF; Pourmasumi S; Mplani V; Servos G; Dousdampanis P; Plotas P; Michalaki MA; Tsigkas G; Grammatikopoulos G; Velissaris D; Koniar I
Balkan Med J; 2024 Jan; 41(1):7-22. PubMed ID: 38173173
[TBL] [Abstract][Full Text] [Related]
33. The role of SARS-CoV-2 target ACE2 in cardiovascular diseases.
Zhu H; Zhang L; Ma Y; Zhai M; Xia L; Liu J; Yu S; Duan W
J Cell Mol Med; 2021 Feb; 25(3):1342-1349. PubMed ID: 33443816
[TBL] [Abstract][Full Text] [Related]
34. Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney.
Jiang X; Eales JM; Scannali D; Nazgiewicz A; Prestes P; Maier M; Denniff M; Xu X; Saluja S; Cano-Gamez E; Wystrychowski W; Szulinska M; Antczak A; Byars S; Skrypnik D; Glyda M; Król R; Zywiec J; Zukowska-Szczechowska E; Burrell LM; Woolf AS; Greenstein A; Bogdanski P; Keavney B; Morris AP; Heagerty A; Williams B; Harrap SB; Trynka G; Samani NJ; Guzik TJ; Charchar FJ; Tomaszewski M
Eur Heart J; 2020 Dec; 41(48):4580-4588. PubMed ID: 33206176
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
[TBL] [Abstract][Full Text] [Related]
37. Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19.
Morganstein T; Haidar Z; Trivlidis J; Azuelos I; Huang MJ; Eidelman DH; Baglole CJ
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884756
[TBL] [Abstract][Full Text] [Related]
38. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
39. Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases.
Tanzadehpanah H; Lotfian E; Avan A; Saki S; Nobari S; Mahmoodian R; Sheykhhasan M; Froutagh MHS; Ghotbani F; Jamshidi R; Mahaki H
Biomed Pharmacother; 2023 Oct; 166():115321. PubMed ID: 37597321
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells.
Caputo I; Caroccia B; Frasson I; Poggio E; Zamberlan S; Morpurgo M; Seccia TM; Calì T; Brini M; Richter SN; Rossi GP
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]